StreetInsider.com After-Hours Movers 03/21

StreetInsider.com After-Hours Movers:

RCM Technologies, Inc. (Nasdaq: RCMT) 25% HIGHER; reported revenues of $54.2 million for the thirteen weeks ended December 30, 2006, up from $46.8 million for the thirteen weeks ended December 31, 2005. Net income for the thirteen weeks ended December 30, 2006 was $2.3 million, or $.19 per diluted share, as compared to net income of $818,500, or $.07 per diluted share, for the comparable prior year period.

Herman Miller (Nasdaq: MLHR) 6.8% LOWER; reports Q3 EPS of $0.50, 2 cents worse than estimates.(0.52) Revenues were $484.8 million vs. $491.41 million consensus. Sees Q4 EPS of $0.47-$0.51, versus the consensus of $0.52. Sees Q4 revenues of $485-$505 million versus the consensus of $491.4 million.

Intuit Inc. (Nasdaq: INTU) 6% LOWER; said through March 17, 2007, total TurboTax federal unit sales increased 1 percent over the same period last year. For the full season, we expect total unit growth of 3 percent to 5 percent. Intuit also reiterated its fiscal 2007 guidance for the company and other segments.

Motorola, Inc. (NYSE: MOT) 5.3% LOWER; revised lower its previously announced first quarter 2007 guidance, announced an accelerated repurchase of $2.0 billion of common stock and increases its existing share repurchase program to $7.5 billion. Motorola now expects sales for the first quarter of 2007 to be in the range of $9.2 to $9.3 billion. First quarter GAAP results are expected to be a loss in the range of $0.07 to $0.09 per share, including charges of approximately $0.09 from the items highlighted below. The consensus is sales of $10.46 billion and EPS of $0.17 (may not compare). Also announces management changes.

Ligand Pharmaceuticals (NASDAQ: LGND) 4% HIGHER; announced return of cash on the common stock of the Corporation in the form of a $2.50 per share cash dividend, payable on April 19, 2007 to shareholders of record as of April 5, 2007. In addition to this approximately $253 million cash dividend, Ligand's board of directors has authorized up to $100 million in share repurchases within the next 12 months.

Citi Trends (Nasdaq: CTRN) 3.7% LOWER; reports Q4 EPS of $0.73, 4 cents better than estimates.(0.69) Revenues were $126.8 million vs. $124.44 million consensus. Sees Q1 EPS of $0.44-$0.49, versus the consensus of $0.56. Reaffirms FY07 forecast.

Adams Respiratory Therapeutics Inc. (ARXT) 3% HIGHER; entered into a settlement agreement with Mutual Pharmaceutical Co. and United Research Laboratories, Inc., both wholly owned subsidiaries of Pharmaceutical Holdings

You May Also Be Interested In

• After-Hours Movers: QCOM, COHR, APP, HUBS, SNAP, FSLY, FIG, ZG, BROS, CDE
• Grail tumbles as revenue misses estimates despite FDA vote
• Cirrus Logic falls on weak third quarter revenue guidance